What is SIGA's current stock price?

SIGA (SIGA Technologies, Inc.) is currently trading at $4.68 with a market cap of $335.7M.

What sector is SIGA Technologies, Inc. in?

SIGA Technologies, Inc. (SIGA) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

InvestLog

SIGA SIGA Technologies, Inc.

Healthcare

$4.68-0.64%ClosedMarket Cap: $335.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

13.92

PEG

—

P/B

2.21

P/S

3.58

EV/EBITDA

7.78

DCF Value

$9.81

FCF Yield

8.2%

Div Yield

12.8%

Margins & Returns

Gross Margin

65.4%

Operating Margin

22.0%

Net Margin

21.6%

ROE

10.6%

ROA

9.2%

ROIC

10.0%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$6.2M	$-3.5M	$—
Q4 null	$3.8M	$-5.4M	$—
FY null	$94.6M	$23.3M	$—
Q3 null	$2.6M	$-6.4M	$—

Analyst Ratings

View All

Consensus

—

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

Miller Larry R.officer: General Counsel

SellThu Mar 26

Miller Larry R.officer: General Counsel

SellThu Mar 26

Miller Larry R.officer: General Counsel

SellTue Mar 17

Miller Larry R.officer: General Counsel

SellTue Mar 17

Luckshire Daniel Jofficer: Executive VP & CFO

SellTue Mar 17

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Exchange

—

Beta

0.85

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

Peers

EBS